Posts by Carrie Vyhlidal, Ph.D.

BioData-KCAS-Poster-72x36_Final Posters & Papers
Read article Can Automation Improve Compliance, Consistency, & Efficiency for CGTP Data Analysis
Can Automation Improve Compliance, Consistency, & Efficiency for CGTP Data Analysis

Please download this poster, “Can Automation Improve Compliance, Consistency, & Efficiency for CGTP Data Analysis” BioData-KCAS-Poster-72x36_FinalDownload…

KCAS-event_2024-ASGCT Blogs
Read article Can automation of molecular assay data in a highly regulated environment improve quality and provide a competitive advantage?
Can automation of molecular assay data in a highly regulated environment improve quality and provide a competitive advantage?

Arguably the most groundbreaking new opportunities for the treatment of disease and injury are Cell and Gene Therapy Products (CGTP) or what the European Medicines Agency (EMA) call Advanced Therapy Medicinal Products (ATMPs). EMA has broken down ATMPs into three main types: Gene therapy medicines: these…

KCAS-blog-thumb_2023-CGT-Best-PPractices-AAPS-Group Blogs
Read article KCAS Bio is at the Forefront of Establishing Best Practices for qPCR and ddPCR Technologies
KCAS Bio is at the Forefront of Establishing Best Practices for qPCR and ddPCR Technologies

Two of the scientific experts from KCAS Bio have been leaders in determining the direction of qPCR and ddPCR technology for the industry. Carrie Vyhlidal, PhD and Jonathan Mercier are both part of the American Association of Pharmaceutical Scientists’ working group for PCR-based methodology, and they have recently…